| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Clinical Investigations |
1 Cardiovascular Center, Nuclear Cardiology Section, University Hospital Zurich, Zurich, Switzerland
2 Division of Echocardiography, University Hospital Zurich, Zurich, Switzerland
Soft-tissue attenuation artifacts generally appear as fixed perfusion-scan defects. Gated 99mTc-tetrofosmin SPECT may help differentiate myocardial infarction (MI) from artifacts, as fixed defects with decreased function (wall motion and thickening) probably represent MI, whereas attenuation artifacts represent preserved function. Methods: Ungated stress and gated rest 99mTc-tetrofosmin SPECT was performed on 153 consecutive patients referred for evaluation of coronary artery disease. From stress and summed gated rest images, 107 patients (70%) were identified with isolated fixed defects. The function of the defects was assessed semiquantitatively from gated stress images. The findings were correlated with clinical (history or electrocardiographic Q waves) evidence of MI. Results: Of 62 patients with fixed defects and clinical MI, 60 (97%) had an abnormal defect function. Of 45 patients with no clinical MI, 16 (36%) had decreased function of the defect, possibly indicating silent MI. In 29 of the 45 patients (64%) with no clinical MI, defect function was normal. Because most (90%) fixed defects with normal systolic function occurred in men with inferior fixed defects (87%) or women with anterior fixed defects (3%), these were most likely attenuation artifacts. By reclassifying the condition of patients with fixed defects and normal function as normal, patients with unexplained fixed defects (no clinical MI) decreased from 29% to 10%. Conclusion: Gating adds considerable value to 99mTc-tetrofosmin SPECT myocardial perfusion imaging in characterizing fixed defects and potentially improves test specificity.
Key Words: gated SPECT • tetrofosmin • attenuation artifact • fixed defect • infarct
This article has been cited by other articles:
|
|
 |
|
  O. Gaemperli, L. Husmann, T. Schepis, P. Koepfli, I. Valenta, W. Jenni, H. Alkadhi, T. F. Luscher, and P. A. Kaufmann Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a potential gatekeeper for coronary revascularization? Eur. Heart J., December 1, 2009; 30(23): 2921 - 2929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Kaufmann, P. G. Camici, and S. R. Underwood CHAPTER 7 Nuclear Cardiology ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Baggish and C. A. Boucher Radiopharmaceutical Agents for Myocardial Perfusion Imaging Circulation, October 14, 2008; 118(16): 1668 - 1674. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Gaemperli, T. Schepis, I. Valenta, P. Koepfli, L. Husmann, H. Scheffel, S. Leschka, F. R. Eberli, T. F. Luscher, H. Alkadhi, et al. Functionally Relevant Coronary Artery Disease: Comparison of 64-Section CT Angiography with Myocardial Perfusion SPECT Radiology, August 1, 2008; 248(2): 414 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schepis, O. Gaemperli, P. Koepfli, M. Namdar, I. Valenta, H. Scheffel, S. Leschka, L. Husmann, F. R. Eberli, T. F. Luscher, et al. Added Value of Coronary Artery Calcium Score as an Adjunct to Gated SPECT for the Evaluation of Coronary Artery Disease in an Intermediate-Risk Population J. Nucl. Med., September 1, 2007; 48(9): 1424 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Gaemperli, T. Schepis, I. Valenta, L. Husmann, H. Scheffel, V. Duerst, F. R. Eberli, T. F. Luscher, H. Alkadhi, and P. A. Kaufmann Cardiac Image Fusion from Stand-Alone SPECT and CT: Clinical Experience J. Nucl. Med., May 1, 2007; 48(5): 696 - 703. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
